SB INVESTMENT ADVISERS (UK) LTD
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 1731509
LONDON, X0
Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,052,324
+$2,308,556 QoQ
Shares Held
610,729
0.0% QoQ
Ownership
0.907%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#15
of 183 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SB INVESTMENT ADVISERS (UK) LTD holds $639,715,248 across 3 Biotechnology names. DNA ranks #3 (0.9% of the industry book) .
All Filings in DNA
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,052,324 | 610,729 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,743,768 | 610,729 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $5,075,157 | 610,729 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $8,904,428 | 610,729 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,870,701 | 610,729 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $3,481,155 | 610,729 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,997,358 | 610,729 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,977,441 | 610,729 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,159,349 | 24,429,191 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $28,337,861 | 24,429,191 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $41,285,332 | 24,429,191 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $44,216,835 | 24,429,191 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $45,438,295 | 24,429,191 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $32,490,824 | 24,429,191 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $41,285,332 | 24,429,191 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||